Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 11
2003 4
2004 12
2005 19
2006 23
2007 12
2008 14
2009 27
2010 23
2011 22
2012 22
2013 24
2014 26
2015 33
2016 23
2017 28
2018 18
2019 18
2020 7
2021 5
2022 8
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

338 results

Results by year

Filters applied: . Clear all
Page 1
Prevention in Hepatology.
Muñoz-Restrepo AM, Navas MC, Daza J, Girala M, Ridruejo E, Gerken G, Teufel A. Muñoz-Restrepo AM, et al. Among authors: gerken g. J Pers Med. 2024 Jan 23;14(2):132. doi: 10.3390/jpm14020132. J Pers Med. 2024. PMID: 38392566 Free PMC article. Review.
Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial.
Zhu AX, Kang YK, Yen CJ, Finn RS, Galle PR, Llovet JM, Assenat E, Brandi G, Pracht M, Lim HY, Rau KM, Motomura K, Ohno I, Merle P, Daniele B, Shin DB, Gerken G, Borg C, Hiriart JB, Okusaka T, Morimoto M, Hsu Y, Abada PB, Kudo M; REACH-2 study investigators. Zhu AX, et al. Among authors: gerken g. Lancet Oncol. 2019 Feb;20(2):282-296. doi: 10.1016/S1470-2045(18)30937-9. Epub 2019 Jan 18. Lancet Oncol. 2019. PMID: 30665869 Clinical Trial.
[Hepatic encephalopathy].
Hilgard P, Gerken G. Hilgard P, et al. Among authors: gerken g. Med Klin (Munich). 2004 Oct 15;99(10):591-602. doi: 10.1007/s00063-004-1090-x. Med Klin (Munich). 2004. PMID: 15490075 Review. German.
Tivantinib for the treatment of hepatocellular carcinoma.
Best J, Schotten C, Lohmann G, Gerken G, Dechêne A. Best J, et al. Among authors: gerken g. Expert Opin Pharmacother. 2017 May;18(7):727-733. doi: 10.1080/14656566.2017.1316376. Epub 2017 Apr 17. Expert Opin Pharmacother. 2017. PMID: 28414564 Review.
Challenges in Liver Transplantation.
Gerken G, Paul A. Gerken G, et al. Visc Med. 2016 Aug;32(4):232-233. doi: 10.1159/000448633. Epub 2016 Aug 15. Visc Med. 2016. PMID: 27722158 Free PMC article. No abstract available.
Novel implications in the treatment of hepatocellular carcinoma.
Best J, Schotten C, Theysohn JM, Wetter A, Müller S, Radünz S, Schulze M, Canbay A, Dechêne A, Gerken G. Best J, et al. Among authors: gerken g. Ann Gastroenterol. 2017;30(1):23-32. doi: 10.20524/aog.2016.0092. Epub 2016 Sep 30. Ann Gastroenterol. 2017. PMID: 28042235 Free PMC article. Review.
Apoptosis in immune-mediated liver diseases.
Kahraman A, Gerken G, Canbay A. Kahraman A, et al. Among authors: gerken g. Dig Dis. 2010;28(1):144-9. doi: 10.1159/000299799. Epub 2010 May 7. Dig Dis. 2010. PMID: 20460903 Review.
Liver Failure due to Acute Viral Hepatitis (A-E).
Manka P, Verheyen J, Gerken G, Canbay A. Manka P, et al. Among authors: gerken g. Visc Med. 2016 Apr;32(2):80-5. doi: 10.1159/000444915. Epub 2016 Apr 7. Visc Med. 2016. PMID: 27413724 Free PMC article. Review.
Apoptosis in selected liver diseases.
Kiliçarslan A, Kahraman A, Akkiz H, Yildiz Menziletoğlu S, Fingas CD, Gerken G, Canbay A. Kiliçarslan A, et al. Among authors: gerken g. Turk J Gastroenterol. 2009 Sep;20(3):171-9. doi: 10.4318/tjg.2009.0003. Turk J Gastroenterol. 2009. PMID: 19821198 Free article. Review.
338 results